Home Cart Sign in  
Chemical Structure| 149676-40-4 Chemical Structure| 149676-40-4

Structure of Pefloxacin mesylate dihydrate
CAS No.: 149676-40-4

Chemical Structure| 149676-40-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pefloxacin mesylate, antibacterial agent, can prevent bacterial DNA replication via inhibiting DNA gyrase or topoisomerse.

Synonyms: Pefloxacinium mesylate dihydrate; Pefloxacin (mesylate hydrate); Peflacin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pefloxacin mesylate dihydrate

CAS No. :149676-40-4
Formula : C18H28FN3O8S
M.W : 465.49
SMILES Code : O=C(C1=CN(CC)C2=C(C=C(F)C(N3CCN(C)CC3)=C2)C1=O)O.CS(=O)(O)=O.[H]O[H].[H]O[H]
Synonyms :
Pefloxacinium mesylate dihydrate; Pefloxacin (mesylate hydrate); Peflacin
MDL No. :MFCD01685696
InChI Key :LEULAXMUNMRLPW-UHFFFAOYSA-N
Pubchem ID :6917670

Safety of Pefloxacin mesylate dihydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H319
Precautionary Statements:P305+P351+P338

Related Pathways of Pefloxacin mesylate dihydrate

DNA

Isoform Comparison

Biological Activity

Target
  • Topo II

In Vitro:

Cell Line
Concentration Treated Time Description References
Salmonella enterica 5 μg 16-20 hours To evaluate the ability of pefloxacin disk diffusion method to detect fluoroquinolone-resistant Salmonella enterica. Results showed that the 5 μg pefloxacin disk correctly identified all resistant isolates. J Clin Microbiol. 2015 Nov;53(11):3411-7
Xenopus oocytes expressing human α4β2 nAChRs 100 µM 30 s preapplication + 5 s coapplication To investigate the inhibitory effects of Pefloxacin on two stoichiometries of α4β2 nAChRs. Results showed that Pefloxacin significantly inhibited (α4)2(β2)3 nAChRs (inhibition of 73.3 ± 1.9%) but had no significant effect on (α4)3(β2)2 nAChRs. ACS Chem Neurosci. 2022 Jun 15;13(12):1805-1817

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Male Sprague-Dawley rats Intravenous injection 10 mg/kg Single dose To investigate the pharmacokinetics of pefloxacin and its interaction with cyclosporin A in rat blood, brain, and bile. Results showed that pefloxacin could penetrate the blood-brain barrier, and the concentration in bile was higher than in blood, suggesting active biliary excretion of pefloxacin. Cyclosporin A had no significant impact on the pharmacokinetics of pefloxacin in rat blood and brain. Br J Pharmacol. 2001 Mar;132(6):1310-6
Mice Normal mice Oral 400 mg/kg Single dose Measure proteoglycan synthesis, observed early inhibition followed by a repair-like response Antimicrob Agents Chemother. 2000 Apr;44(4):867-72

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.15mL

0.43mL

0.21mL

10.74mL

2.15mL

1.07mL

21.48mL

4.30mL

2.15mL

References

 

Historical Records

Categories